Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100007 |
Resumo: | SUMMARY OBJECTIVE: Several prospective randomized trials have shown that hypofractionation has the same efficacy and safety as the conventional fractionation in the treatment of localized prostate cancer. There are many benefits of hypofractionation, including a more convenient schedule for the patients and better use of resources, which is especially important in low- and middle-income countries like Brasil. Based on these data, the Brazilian Society of Radiotherapy (Sociedade Brasileira de Radioterapia) organized this consensus to guide and support the use of hypofractionated radiotherapy for localized prostate cancer in Brasil. METHODS: The relevant literature regarding moderate hypofractionation (mHypo) and ultra-hypofractionation (uHypo) was reviewed and discussed by a group of experts from public and private centers of different parts of Brasil. Several key questions concerning clinical indications, outcomes and technological requirements for hypofractionation were discussed and voted. For each question, consensus was reached if there was an agreement of at least 75% of the panel members. RESULTS: The recommendations are described in this article. CONCLUSION: This initiative will assist Brazilian radiation oncologists and medical physicists to safely treat localized prostate cancer patients with hypofractionation. |
id |
AMB-1_41a6c96fd6ac8a7932c54e14d8831935 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302021000100007 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Hypofractionated radiotherapy recommendations for localized prostate cancer in BrazilProstatic neoplasmsRadiotherapyRadiation dose hypofractionationConsensusSUMMARY OBJECTIVE: Several prospective randomized trials have shown that hypofractionation has the same efficacy and safety as the conventional fractionation in the treatment of localized prostate cancer. There are many benefits of hypofractionation, including a more convenient schedule for the patients and better use of resources, which is especially important in low- and middle-income countries like Brasil. Based on these data, the Brazilian Society of Radiotherapy (Sociedade Brasileira de Radioterapia) organized this consensus to guide and support the use of hypofractionated radiotherapy for localized prostate cancer in Brasil. METHODS: The relevant literature regarding moderate hypofractionation (mHypo) and ultra-hypofractionation (uHypo) was reviewed and discussed by a group of experts from public and private centers of different parts of Brasil. Several key questions concerning clinical indications, outcomes and technological requirements for hypofractionation were discussed and voted. For each question, consensus was reached if there was an agreement of at least 75% of the panel members. RESULTS: The recommendations are described in this article. CONCLUSION: This initiative will assist Brazilian radiation oncologists and medical physicists to safely treat localized prostate cancer patients with hypofractionation.Associação Médica Brasileira2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100007Revista da Associação Médica Brasileira v.67 n.1 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.67.01.002info:eu-repo/semantics/openAccessPalhares,Daniel Moore FreitasPimentel,Leonardo Cunha FurbinoCastilho,Marcus SimõesCosta,Andréa Barleze daReisner,Márcio LembergKuhnen,Felipe QuintinoPássaro,AndersonLeite,Elton Trigo TeixeiraFaustino,Fábio de Lima CostaObst,Fernando MarianoCosta,Flávio Napoleão Buarque Barbosa FerroPioner,Giovani ThomazCarvalho,Ícaro Thiago deSilva,João Luís Fernandes daMorikawa,Lisa Karina KokayZanuncio,Pedro Henrique da RochaHanriot,Rodrigo de MoraisRosa,Arthur Acciolyeng2021-11-11T00:00:00Zoai:scielo:S0104-42302021000100007Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-11-11T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
title |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
spellingShingle |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil Palhares,Daniel Moore Freitas Prostatic neoplasms Radiotherapy Radiation dose hypofractionation Consensus |
title_short |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
title_full |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
title_fullStr |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
title_full_unstemmed |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
title_sort |
Hypofractionated radiotherapy recommendations for localized prostate cancer in Brazil |
author |
Palhares,Daniel Moore Freitas |
author_facet |
Palhares,Daniel Moore Freitas Pimentel,Leonardo Cunha Furbino Castilho,Marcus Simões Costa,Andréa Barleze da Reisner,Márcio Lemberg Kuhnen,Felipe Quintino Pássaro,Anderson Leite,Elton Trigo Teixeira Faustino,Fábio de Lima Costa Obst,Fernando Mariano Costa,Flávio Napoleão Buarque Barbosa Ferro Pioner,Giovani Thomaz Carvalho,Ícaro Thiago de Silva,João Luís Fernandes da Morikawa,Lisa Karina Kokay Zanuncio,Pedro Henrique da Rocha Hanriot,Rodrigo de Morais Rosa,Arthur Accioly |
author_role |
author |
author2 |
Pimentel,Leonardo Cunha Furbino Castilho,Marcus Simões Costa,Andréa Barleze da Reisner,Márcio Lemberg Kuhnen,Felipe Quintino Pássaro,Anderson Leite,Elton Trigo Teixeira Faustino,Fábio de Lima Costa Obst,Fernando Mariano Costa,Flávio Napoleão Buarque Barbosa Ferro Pioner,Giovani Thomaz Carvalho,Ícaro Thiago de Silva,João Luís Fernandes da Morikawa,Lisa Karina Kokay Zanuncio,Pedro Henrique da Rocha Hanriot,Rodrigo de Morais Rosa,Arthur Accioly |
author2_role |
author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Palhares,Daniel Moore Freitas Pimentel,Leonardo Cunha Furbino Castilho,Marcus Simões Costa,Andréa Barleze da Reisner,Márcio Lemberg Kuhnen,Felipe Quintino Pássaro,Anderson Leite,Elton Trigo Teixeira Faustino,Fábio de Lima Costa Obst,Fernando Mariano Costa,Flávio Napoleão Buarque Barbosa Ferro Pioner,Giovani Thomaz Carvalho,Ícaro Thiago de Silva,João Luís Fernandes da Morikawa,Lisa Karina Kokay Zanuncio,Pedro Henrique da Rocha Hanriot,Rodrigo de Morais Rosa,Arthur Accioly |
dc.subject.por.fl_str_mv |
Prostatic neoplasms Radiotherapy Radiation dose hypofractionation Consensus |
topic |
Prostatic neoplasms Radiotherapy Radiation dose hypofractionation Consensus |
description |
SUMMARY OBJECTIVE: Several prospective randomized trials have shown that hypofractionation has the same efficacy and safety as the conventional fractionation in the treatment of localized prostate cancer. There are many benefits of hypofractionation, including a more convenient schedule for the patients and better use of resources, which is especially important in low- and middle-income countries like Brasil. Based on these data, the Brazilian Society of Radiotherapy (Sociedade Brasileira de Radioterapia) organized this consensus to guide and support the use of hypofractionated radiotherapy for localized prostate cancer in Brasil. METHODS: The relevant literature regarding moderate hypofractionation (mHypo) and ultra-hypofractionation (uHypo) was reviewed and discussed by a group of experts from public and private centers of different parts of Brasil. Several key questions concerning clinical indications, outcomes and technological requirements for hypofractionation were discussed and voted. For each question, consensus was reached if there was an agreement of at least 75% of the panel members. RESULTS: The recommendations are described in this article. CONCLUSION: This initiative will assist Brazilian radiation oncologists and medical physicists to safely treat localized prostate cancer patients with hypofractionation. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100007 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100007 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.67.01.002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.67 n.1 2021 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212835675602944 |